TABLE 3.
Toxicity data
| Oxaliplatin Group |
Cisplatin Group |
OR for Toxicity in Cisplatin (Reference: Oxaliplatin) |
||
|---|---|---|---|---|
| No. Patients, n (%) | No. Patients, n (%) | P | Estimate (95% Confidence Interval); P | |
| Myeloid | ||||
| Yes | 6 (22.2) | 7 (36.8) | 0.33 | 2.16 (0.57–8.19); 0.26 |
| No | 21 (77.8) | 12 (63.2) | Reference | |
| Nephrotoxicity | ||||
| Yes | 0 (0) | 2 (10.5) | 0.22 | N/A |
| No | 27 (100) | 17 (89.5) | ||
| Neurotoxicity | ||||
| Yes | 7 (25.9) | 13 (68.4) | 0.01 | 8.51 (1.96–36.90); <0.01 |
| No | 20 (74.1) | 6 (31.6) | Reference | |
| GI (oral thrush) | ||||
| Yes | 2 (7.4) | 1 (5.3) | 1 | N/A |
| No | 25 (92.6) | 18 (94.8) | ||
| GI (emesis) | ||||
| Yes | 0 | 0 | N/A | |
| No | 27 (100) | 19 (100) | ||
| Dermatologic | ||||
| Yes | 1 (3.7) | 0 (0) | 1 | N/A |
| No | 26 (96.3) | 19 (100) |
N/A, not available.